Rumo S.A (RAIL3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 18.62 |
|---|---|
| 52-week range | 12.16 – 19.37 |
| Return, 1 month / 3 months | +17.3% / +33.4% |
| Return, 1 year / 3 years | +20.6% / −12.3% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -27.6% |
| Average daily value traded | 210.85M BRL |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Rumo is a Brazilian logistics company that runs freight railways and related terminal operations, moving agricultural commodities such as grain and sugar along with fuel, containers and other cargo. It serves producers, traders and industrial customers who need long-distance transport between Brazil's interior and its ports. The company is based in São Paulo state and combines rail haulage with port and transshipment services to connect inland growing regions with export terminals.
The shares are listed on the B3 Stock Exchange in Brazil under the code RAIL3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Rumo S.A (RAIL3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 18.62 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 211 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.6% and over the last three months it rose 33.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.8% | ||
| From 52-week high | -2.3% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 33.4% | ||
| 6-month return | 17.8% | ||
| 12-month return, skipping the last month | 2.8% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.6% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 210.85M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | +17.3% |
| 3 months | +33.4% |
| 6 months | +17.8% |
| 1 year | +20.6% |
| 3 years | −12.3% |
| 5 years | +19.1% |
Signals
| 50-day / 200-day average | 15.53 / 15.04 |
|---|---|
| Golden / death cross (60 days) | Golden, 6 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | BRL 0.1084 |
| 16 Jun 2025 | BRL 0.8104 |
| 30 Apr 2024 | BRL 0.0924 |
| 19 Apr 2023 | BRL 0.0660 |
| 27 Apr 2022 | BRL 0.0193 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.